Cogent Biosciences (COGT) Change in Account Payables (2017 - 2021)
Historic Change in Account Payables for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to -$866000.0.
- Cogent Biosciences' Change in Account Payables fell 103118.28% to -$866000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.8 million, marking a year-over-year increase of 21223.99%. This contributed to the annual value of $1.4 million for FY2024, which is 7178.47% down from last year.
- Latest data reveals that Cogent Biosciences reported Change in Account Payables of -$866000.0 as of Q4 2021, which was down 103118.28% from $2.4 million recorded in Q3 2021.
- Cogent Biosciences' 5-year Change in Account Payables high stood at $2.4 million for Q3 2021, and its period low was -$2.6 million during Q1 2020.
- In the last 5 years, Cogent Biosciences' Change in Account Payables had a median value of $5500.0 in 2020 and averaged $115000.0.
- The largest annual percentage gain for Cogent Biosciences' Change in Account Payables in the last 5 years was 4182500.0% (2021), contrasted with its biggest fall of 103118.28% (2021).
- Quarter analysis of 5 years shows Cogent Biosciences' Change in Account Payables stood at -$774000.0 in 2017, then skyrocketed by 192.51% to $716000.0 in 2018, then surged by 121.93% to $1.6 million in 2019, then plummeted by 94.15% to $93000.0 in 2020, then crashed by 1031.18% to -$866000.0 in 2021.
- Its Change in Account Payables was -$866000.0 in Q4 2021, compared to $2.4 million in Q3 2021 and $1.7 million in Q2 2021.